Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 May;68(5):632–636. doi: 10.1136/adc.68.5.632

Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.

L V Nicholson 1, M A Johnson 1, K M Bushby 1, D Gardner-Medwin 1
PMCID: PMC1029331  PMID: 8323331

Abstract

The age when boys lose the ability to walk independently is one of the milestones in the progression of Duchenne muscular dystrophy (DMD). We have used this as a measure of disease severity in a group of 30 patients with DMD and six patients with intermediate Duchenne/Becker dystrophy (D/BMD). Dystrophin analysis was performed on tissue sections and western blots of muscle biopsy specimens from these patients and the relationships that were found between clinical severity and abundance of dystrophin labelling are reported. All patients with intermediate D/BMD had dystrophin labelling that was detected on sections and blots. Weak dystrophin labelling was found in sections from 21/30 DMD cases and on blots in 18/30 cases. Two non-exclusive patterns of dystrophin labelling were observed on sections: very clear labelling on a small percentage of fibres (usually < 1%) or very weak labelling on a much higher proportion (about 25%). The mean age at loss of mobility among the DMD patients with no dystrophin labelling on tissue sections was 7.9 years (range 6.3-9.5) while the mean age among those with some labelling was 9.9 years (range 8.0-11.9); this is a significant difference. Quantitative estimates of dystrophin abundance were obtained from densitometric analysis of dystrophin bands on blots. In the whole group of 36 patients, a significant positive relationship was found between the abundance of dystrophin and the age at loss of independent mobility. It is concluded that even the very low concentrations of dystrophin found in DMD patients may have some functional significance.

Full text

PDF
632

Images in this article

634Image
on p.634
634Image
on p.634

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arahata K., Beggs A. H., Honda H., Ito S., Ishiura S., Tsukahara T., Ishiguro T., Eguchi C., Orimo S., Arikawa E. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci. 1991 Feb;101(2):148–156. doi: 10.1016/0022-510x(91)90039-a. [DOI] [PubMed] [Google Scholar]
  2. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., Ishihara T., Nonaka I., Ozawa E., Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature. 1988 Jun 30;333(6176):861–863. doi: 10.1038/333861a0. [DOI] [PubMed] [Google Scholar]
  3. Augier N., Boucraut J., Léger J., Anoal M., Nicholson L. V., Voelkel M. A., Léger J. J., Pellissier J. F. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence. J Neurol Sci. 1992 Feb;107(2):233–238. doi: 10.1016/0022-510x(92)90294-u. [DOI] [PubMed] [Google Scholar]
  4. Bewick G. S., Nicholson L. V., Young C., O'Donnell E., Slater C. R. Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport. 1992 Oct;3(10):857–860. doi: 10.1097/00001756-199210000-00009. [DOI] [PubMed] [Google Scholar]
  5. Blake D. J., Love D. R., Tinsley J., Morris G. E., Turley H., Gatter K., Dickson G., Edwards Y. H., Davies K. E. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Hum Mol Genet. 1992 May;1(2):103–109. doi: 10.1093/hmg/1.2.103. [DOI] [PubMed] [Google Scholar]
  6. Bonilla E., Samitt C. E., Miranda A. F., Hays A. P., Salviati G., DiMauro S., Kunkel L. M., Hoffman E. P., Rowland L. P. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 1988 Aug 12;54(4):447–452. doi: 10.1016/0092-8674(88)90065-7. [DOI] [PubMed] [Google Scholar]
  7. Chelly J., Gilgenkrantz H., Lambert M., Hamard G., Chafey P., Récan D., Katz P., de la Chapelle A., Koenig M., Ginjaar I. B. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 1990 Dec 21;63(6):1239–1248. doi: 10.1016/0092-8674(90)90419-f. [DOI] [PubMed] [Google Scholar]
  8. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  9. England S. B., Nicholson L. V., Johnson M. A., Forrest S. M., Love D. R., Zubrzycka-Gaarn E. E., Bulman D. E., Harris J. B., Davies K. E. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 1990 Jan 11;343(6254):180–182. doi: 10.1038/343180a0. [DOI] [PubMed] [Google Scholar]
  10. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  11. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988 May 26;318(21):1363–1368. doi: 10.1056/NEJM198805263182104. [DOI] [PubMed] [Google Scholar]
  12. Hoffman E. P., Garcia C. A., Chamberlain J. S., Angelini C., Lupski J. R., Fenwick R. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann Neurol. 1991 Oct;30(4):605–610. doi: 10.1002/ana.410300414. [DOI] [PubMed] [Google Scholar]
  13. Hoffman E. P., Kunkel L. M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989 Jan;2(1):1019–1029. doi: 10.1016/0896-6273(89)90226-2. [DOI] [PubMed] [Google Scholar]
  14. Khurana T. S., Hoffman E. P., Kunkel L. M. Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem. 1990 Oct 5;265(28):16717–16720. [PubMed] [Google Scholar]
  15. Klein C. J., Coovert D. D., Bulman D. E., Ray P. N., Mendell J. R., Burghes A. H. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet. 1992 May;50(5):950–959. [PMC free article] [PubMed] [Google Scholar]
  16. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  17. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  18. Love D. R., Hill D. F., Dickson G., Spurr N. K., Byth B. C., Marsden R. F., Walsh F. S., Edwards Y. H., Davies K. E. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature. 1989 May 4;339(6219):55–58. doi: 10.1038/339055a0. [DOI] [PubMed] [Google Scholar]
  19. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  20. Nicholson L. V., Bushby K. M., Johnson M. A., den Dunnen J. T., Ginjaar I. B., van Ommen G. J. Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet. 1992 Dec;29(12):892–896. doi: 10.1136/jmg.29.12.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nicholson L. V., Davison K., Falkous G., Harwood C., O'Donnell E., Slater C. R., Harris J. B. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci. 1989 Dec;94(1-3):125–136. doi: 10.1016/0022-510x(89)90223-2. [DOI] [PubMed] [Google Scholar]
  22. Nicholson L. V., Davison K., Johnson M. A., Slater C. R., Young C., Bhattacharya S., Gardner-Medwin D., Harris J. B. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci. 1989 Dec;94(1-3):137–146. doi: 10.1016/0022-510x(89)90224-4. [DOI] [PubMed] [Google Scholar]
  23. Nicholson L. V., Johnson M. A., Davison K., O'Donnell E., Falkous G., Barron M., Harris J. B. Dystrophin or a "related protein" in Duchenne muscular dystrophy? Acta Neurol Scand. 1992 Jul;86(1):8–14. doi: 10.1111/j.1600-0404.1992.tb08046.x. [DOI] [PubMed] [Google Scholar]
  24. Nicholson L. V., Johnson M. A., Gardner-Medwin D., Bhattacharya S., Harris J. B. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol. 1990;80(3):239–250. doi: 10.1007/BF00294640. [DOI] [PubMed] [Google Scholar]
  25. Ohlendieck K., Ervasti J. M., Matsumura K., Kahl S. D., Leveille C. J., Campbell K. P. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron. 1991 Sep;7(3):499–508. doi: 10.1016/0896-6273(91)90301-f. [DOI] [PubMed] [Google Scholar]
  26. Pons F., Augier N., Léger J. O., Robert A., Tomé F. M., Fardeau M., Voit T., Nicholson L. V., Mornet D., Léger J. J. A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence. FEBS Lett. 1991 Apr 22;282(1):161–165. doi: 10.1016/0014-5793(91)80468-i. [DOI] [PubMed] [Google Scholar]
  27. Roberts R. G., Barby T. F., Manners E., Bobrow M., Bentley D. R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991 Aug;49(2):298–310. [PMC free article] [PubMed] [Google Scholar]
  28. Roberts R. G., Bobrow M., Bentley D. R. Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2331–2335. doi: 10.1073/pnas.89.6.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Récan D., Chafey P., Leturcq F., Hugnot J. P., Vincent N., Tomé F., Collin H., Simon D., Czernichow P., Nicholson L. V. Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization? J Clin Invest. 1992 Feb;89(2):712–716. doi: 10.1172/JCI115640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vainzof M., Zubrzycka-Gaarn E. E., Rapaport D., Passos-Bueno M. R., Pavanello R. C., Pavanello-Filho I., Zatz M. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein. J Neurol Sci. 1991 Feb;101(2):141–147. doi: 10.1016/0022-510x(91)90038-9. [DOI] [PubMed] [Google Scholar]
  31. Voit T., Haas K., Léger J. O., Pons F., Léger J. J. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies. Am J Pathol. 1991 Nov;139(5):969–976. [PMC free article] [PubMed] [Google Scholar]
  32. Voit T., Stuettgen P., Cremer M., Goebel H. H. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics. 1991 Aug;22(3):152–162. doi: 10.1055/s-2008-1071434. [DOI] [PubMed] [Google Scholar]
  33. Wakayama Y., Jimi T., Takeda A., Misugi N., Kumagai T., Miyake S., Shibuya S. Immunoreactivity of antibodies raised against synthetic peptide fragments predicted from mid portions of dystrophin cDNA. J Neurol Sci. 1990 Jul;97(2-3):241–250. doi: 10.1016/0022-510x(90)90222-9. [DOI] [PubMed] [Google Scholar]
  34. Zubrzycka-Gaarn E. E., Bulman D. E., Karpati G., Burghes A. H., Belfall B., Klamut H. J., Talbot J., Hodges R. S., Ray P. N., Worton R. G. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988 Jun 2;333(6172):466–469. doi: 10.1038/333466a0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES